A pilot study on the effects of probiotic supplementation on neuropsychological performance and micro<scp>RNA</scp>‐29a‐c levels in antiretroviral‐treated<scp>HIV</scp>‐1‐infected patients

Abstract

In conclusion, we observed that HIV patients treated with 6 months of this probiotic supplementation appear to have an improvement in some neurocognitive functions; moreover, this approach is safe and did not modify significantly the levels of miRNA in CSF. Further studies are needed to better understand the contribution of the probiotics in modulating gut-brain-axis in HIV patients.